• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Trump Administration
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Authors Posts by Linda Johnson

    Linda Johnson

    This image provided by Pfizer Inc. shows a new print ad for Viagra, the world's top-selling erectile dysfunction drug. Executives at New York-based Pfizer hope the new ad campaign launching Tuesday, Sept. 30, 2014, which includes print ads in publications and a new 60-second television commercial, will nudge women to broach the subject with their mates. (AP Photo/Pfizer Inc.)
    Business

    Viagra ads target women for 1st time

    Linda Johnson -
    September 30, 2014 3:37 pm
    0
    FILE - In this Thursday, Feb. 28, 2013 file photo, a Merck logo is placed on scientist's lab coat in West Point, Pa. The Food and Drug Administration on Thursday, Sept. 4, 2014 said it has granted accelerated approval to Merck's Keytruda, for treating melanoma that's spread or can't be surgically removed, in patients previously treated with another drug. (AP Photo/Matt Rourke, File)
    Business

    FDA OKs Merck drug, 1st in new cancer drug class

    Linda Johnson -
    September 4, 2014 9:41 pm
    0
    Allergan reviews meeting requests in takeover bid
    Business

    Allergan reviews meeting requests in takeover bid

    Linda Johnson -
    August 23, 2014 6:29 pm
    0
    Allergan sues Valeant, claims fraud in buy attempt
    Business

    Allergan sues Valeant, claims fraud in buy attempt

    Linda Johnson -
    August 1, 2014 9:32 pm
    0
    FILE - This April 20, 2010, file photo, shows an exterior view of Amgen offices in Fremont, Calif.  Biotech drugmaker Amgen Inc. reports quarterly earnings on Tuesday, July 29, 2014. (AP Photo/Paul Sakuma, file)
    Business

    Biotech drugmaker Amgen laying off at least 2,400

    Linda Johnson -
    July 29, 2014 11:17 pm
    0
    This May 4, 2014 photo shows the Pfizer logo on the exterior of a former Pfizer factory, in the Brooklyn borough of New York. The pharmaceutical giant reports quarterly financial results on Tuesday, July 29, 2014.
    Business

    Pfizer’s 2Q profit sinks 79 pct but tops forecasts

    Linda Johnson -
    July 29, 2014 5:37 pm
    0
    In this Thursday, Feb. 28, 2013 photo, Merck scientist Pascale Nantermet conducts research to discover new HIV drugs in West Point, Pa. Merck reports quarterly financial results on Tuesday, July 29, 2014. (AP Photo/Matt Rourke)
    Business

    Merck 2Q profit more than doubles

    Linda Johnson -
    July 29, 2014 3:44 pm
    0
    FILE - This Oct. 16 2012, file photo, shows Johnson and Johnson products, including Band Aid brand adhesive bandages, arranged for a photo in St. Petersburg, Fla. Johnson & Johnson reports qurterly financial results on Tuesday, July 15, 2014. (AP Photo/Chris O'Meara, File)
    Business

    J&J 2Q profit climbs 13 percent on new-drug sales

    Linda Johnson -
    July 15, 2014 4:27 pm
    0
    Merck to pay $3.85B for hepatitis C drug developer
    Business

    Merck to pay $3.85B for hepatitis C drug developer

    Linda Johnson -
    June 9, 2014 7:31 pm
    0
    FILE - In a Monday, April 5, 2010, file photo, Shane Nantz kicks up a cloud of pollen as he mows the front yard of his west Charlotte, N.C., home. Seasonal allergy sufferers can try newly FDA-approved types of immnotherapy, once-a-day tablets containing freeze-dried grass extract that dissolve quickly under the tongue, steadily lessening the excessive immune reaction much like the shots. (AP Photo/The Charlotte Observer, Todd Sumlin, File)
    Business

    New allergy tablets offer alternative to shots

    Linda Johnson -
    June 2, 2014 10:54 am
    0
    123...12Page 1 of 12
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter